Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001) by Hai-Dong Zhu, Hai-Liang Li, Ming-Sheng Huang, Wei-Zhu Yang, Guo-Wen Yin, Bin-Yan Zhong, Jun-Hui Sun, Zhi-Cheng Jin, Jian-Jian Chen, Nai-Jian Ge, Wen-Bin Ding, Wen-Hui Li, Jin-Hua Huang, Wei Mu, Shan-Zhi Gu, Jia-Ping Li, Hui Zhao, Shu-Wei Wen, Yan-Ming Lei, Yu-Sheng Song, Chun-Wang Yuan, Wei-Dong Wang, Ming Huang, Wei Zhao, Jian-Bing Wu, Song Wang, Xu Zhu, Jian-Jun Han, Wei-Xin Ren, Zai-Ming Lu, Wen-Ge Xing, Yong Fan, Hai-Lan Lin, Zi-Shu Zhang, Guo-Hui Xu, Wen-Hao Hu, Qiang Tu, Hong-Ying Su, Chuan-Sheng Zheng, Yong Chen, Xu-Ya Zhao, Zhu-Ting Fang, Qi Wang, Jin-Wei Zhao, Ai-Bing Xu, Jian Xu, Qing-Hua Wu, Huan-Zhang Niu, Jian Wang, Feng Dai, Dui-Ping Feng, Qing-Dong Li, Rong-Shu Shi, Jia-Rui Li, Guang Yang, Hai-Bin Shi, Jian-Song Ji, Yu-E Liu, Zheng Cai, Po Yang, Yang Zhao, Xiao-Li Zhu, Li-Gong Lu, Gao-Jun Teng, for the CHANCE001 Investigators

Get full text